Prevention of Kidney Transplant Rejection

NCT00005010 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

End-Stage Renal Disease
Chronic Allograft Nephropathy

Interventions

DRUG: Irbesartan
DRUG: Pravastatin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)